The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women: A Systematic Review and Meta-analysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Menopause is generally characterized by a temporary but accelerated loss of muscle mass that is not attenuated by hormone replacement therapy [167] but can be partially offset by resistance exercise [168, 169]”
From Protein Requirements for Master Athletes: Just Older Versions of Their Younger Selves (2021) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Janssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083
Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study
Landi, F., Liperoti, R., Russo, A., Giovannini, S., Tosato, M., Capoluongo, E., Bernabei, R., & Onder, G. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.02.007 · Cited by 938
An overview of sarcopenia: facts and numbers on prevalence and clinical impact
von Haehling, S., Morley, J. E., & Anker, S. D. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0014-2 · Cited by 888
Predictors of skeletal muscle mass in elderly men and women
Baumgartner, R. N., Waters, D. L., Gallagher, D., Morley, J. E., & Garry, P. J. (1999) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00130-4 · Cited by 809
Bias in meta-analysis detected by a simple, graphical
Stuck, A. E., Rubenstein, L. Z., Wieland, D., Vandenbroucke, J. P., Irwig, L., Macaskill, P., Berry, G., Glasziou, P., Seagroatt, V., Stratton, I., et al. (1998) · BMJ · doi:10.1136/bmj.316.7129.469 · Cited by 699
Takahashi, T. A., & Johnson, K. M. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.01.006 · Cited by 355
SIPILÄ, S., TAAFFE, D. R., CHENG, S., PUOLAKKA, J., TOIVANEN, J., & SUOMINEN, H. (2001) · Clinical Science · doi:10.1042/cs1010147 · Cited by 230
Research works printed but not linked: 51
- Austad, 2006, Why women live longer than men: sex differences in longevity., Gend Med, 3, 79, 10.1016/S1550-8579(06)80198-1 · DOI · Paper page
- Kirchengast, 2009, Gender and age differences in lean soft tissue mass and sarcopenia among healthy elderly., Anthropol Anz, 67, 139, 10.1127/0003-5548/2009/0018 · DOI
- Shafiee, 2017, Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies., J Diabetes Metab Disord, 16, 21, 10.1186/s40200-017-0302-x · DOI · Paper page
- Scott, 2014, Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults., Osteoporos Int, 25, 187, 10.1007/s00198-013-2431-5 · DOI
- Tanimoto, 2014, Sarcopenia and falls in community-dwelling elderly subjects in Japan: defining sarcopenia according to criteria of the European Working Group on Sarcopenia in Older People., Arch Gerontol Geriatr, 59, 295, 10.1016/j.archger.2014.04.016 · DOI
- Gariballa, 2013, Sarcopenia: prevalence and prognostic significance in hospitalized patients., Clin Nutr, 32, 772, 10.1016/j.clnu.2013.01.010 · DOI · Paper page
- Kim, 2014, Sarcopenia: an independent predictor of mortality in community-dwelling older Korean men., J Gerontol A Biol Sci Med Sci, 69, 1244, 10.1093/gerona/glu050 · DOI
- Landi, 2013, Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study., Age Ageing, 42, 203, 10.1093/ageing/afs194 · DOI · Paper page
- Tankó, 2002, The effect of hormone replacement therapy on appendicular lean tissue mass in early postmenopausal women., Menopause, 9, 117, 10.1097/00042192-200203000-00006 · DOI · Paper page
- Brown, 1997, Hormone replacement therapy does not augment gains in muscle strength or fat-free mass in response to weight-bearing exercise., J Gerontol A Biol Sci Med Sci, 52, B166, 10.1093/gerona/52A.3.B166 · DOI · Paper page
- Dayal, 2005, Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids., J Womens Health (Larchmt), 14, 391, 10.1089/jwh.2005.14.391 · DOI
- Greeves, 1999, Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy., Clin Sci (Lond), 97, 79, 10.1042/cs0970079 · DOI
- Bemben, 2002, Relationship between estrogen use and musculoskeletal function in postmenopausal women., Maturitas, 42, 119, 10.1016/S0378-5122(02)00033-6 · DOI
- Taaffe, 2005, Estrogen replacement, muscle composition, and physical function: The Health ABC Study., Med Sci Sports Exerc, 37, 1741, 10.1249/01.mss.0000181678.28092.31 · DOI
- Dubé, 1976, Androgen and estrogen binding in rat skeletal and perineal muscles., Can J Biochem, 54, 50, 10.1139/o76-008 · DOI
- VanBrocklin, 1992, Preparation and evaluation of 17-ethynyl-substituted 16 a-[18F]fluoroestradiols: selective receptor-based PET imaging agents., Int J Rad Appl Instrum B, 19, 363, 10.1016/0883-2897(92)90122-F · DOI
- Friend, 1996, Both oral and transdermal estrogen increase growth hormone release in postmenopausal women—a clinical research center study., J Clin Endocrinol Metab, 81, 2250
- Dionne, 2000, Sarcopenia and muscle function during menopause and hormone-replacement therapy., J Nutr Health Aging, 4, 156
- D’Eon, 2002, The roles of estrogen and progesterone in regulating carbohydrate and fat utilization at rest and during exercise., J Womens Health Gend Based Med, 11, 225, 10.1089/152460902753668439 · DOI
- Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial., JAMA, 288, 321, 10.1001/jama.288.3.321 · DOI · Paper page
- Hodis, 2011, A “window of opportunity”: the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent., Brain Res, 1379, 244, 10.1016/j.brainres.2010.10.076 · DOI · Paper page
- Hodis, 2012, The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective., Climacteric, 15, 217, 10.3109/13697137.2012.656401 · DOI
- Greising, 2009, Hormone therapy and skeletal muscle strength: a meta-analysis., J Gerontol A Biol Sci Med Sci, 64, 1071, 10.1093/gerona/glp082 · DOI
- Tiidus, 2011, Benefits of estrogen replacement for skeletal muscle mass and function in post-menopausal females: evidence from human and animal studies., Eurasian J Med, 43, 109, 10.5152/eajm.2011.24 · DOI
- Gambacciani, 2001, Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy., Maturitas, 39, 125, 10.1016/S0378-5122(01)00194-3 · DOI · Paper page
- Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration., PLoS Med, 6, e1000100, 10.1371/journal.pmed.1000100 · DOI · Paper page
- Higgins, 2011, The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials., BMJ, 343, d5928, 10.1136/bmj.d5928 · DOI · Paper page
- Begg, 1994, Operating characteristics of a rank correlation test for publication bias., Biometrics, 50, 1088, 10.2307/2533446 · DOI · Paper page
- Gambacciani, 2001, Hormone replacement therapy: the benefits in tailoring the regimen and dose., Maturitas, 40, 195, 10.1016/S0378-5122(01)00281-X · DOI
- Lindsay, 1984, The minimum effective dose of estrogen for prevention of postmenopausal bone loss., Obstet Gynecol, 63, 759
- Panay, 2007, Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief., Climacteric, 10, 120, 10.1080/13697130701298107 · DOI
- Blackman, 2002, Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial., JAMA, 288, 2282, 10.1001/jama.288.18.2282 · DOI · Paper page
- Haarbo, 1991, Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause., Metabolism, 40, 1323, 10.1016/0026-0495(91)90037-W · DOI · Paper page
- Pöllänen, 2007, Muscular transcriptome in postmenopausal women with or without hormone replacement., Rejuvenation Res, 10, 485, 10.1089/rej.2007.0536 · DOI
- de Villiers, 2013, Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health., Climacteric, 16, 316, 10.3109/13697137.2013.795683 · DOI · Paper page
- Santen, 2010, Postmenopausal hormone therapy: an Endocrine Society scientific statement., J Clin Endocrinol Metab, 95, s1, 10.1210/jc.2009-2509 · DOI · Paper page
- Branski, 2010, Measurement of body composition in burned children: is there a gold standard?, JPEN J Parenter Enteral Nutr, 34, 55, 10.1177/0148607109336601 · DOI
- Chen, 2005, Postmenopausal hormone therapy and body composition—a substudy of the estrogen plus progestin trial of the Women’s Health Initiative., Am J Clin Nutr, 82, 651, 10.1093/ajcn/82.3.651 · DOI · Paper page
- Hassager, 1989, Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women., Metabolism, 38, 662, 10.1016/0026-0495(89)90104-2 · DOI
- Sørensen, 2001, Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy., Obes Res, 9, 622, 10.1038/oby.2001.81 · DOI
- Aloia, 1995, The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass., Am J Obstet Gynecol, 172, 896, 10.1016/0002-9378(95)90018-7 · DOI
- Evans, 2001, Effects of HRT and exercise training on insulin action, glucose tolerance, and body composition in older women., J Appl Physiol (1985), 90, 2033, 10.1152/jappl.2001.90.6.2033 · DOI
- Washburn, 1993, The Physical Activity Scale for the Elderly (PASE): development and evaluation., J Clin Epidemiol, 46, 153, 10.1016/0895-4356(93)90053-4 · DOI · Paper page
- Bea, 2015, Risk of mortality according to body mass index and body composition among postmenopausal women., Am J Epidemiol, 182, 585, 10.1093/aje/kwv103 · DOI · Paper page
- Coraci, 2016, Comment on “Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition.”, Clin Nutr, 35, 1568, 10.1016/j.clnu.2016.06.026 · DOI
- Maltais, 2009, Changes in muscle mass and strength after menopause., J Musculoskelet Neuronal Interact, 9, 186
- Ryan, 1995, Resistive training increases fat-free mass and maintains RMR despite weight loss in postmenopausal women., J Appl Physiol (1985), 79, 818, 10.1152/jappl.1995.79.3.818 · DOI
- Goulet, 2005, No sustained effect of aerobic or resistance training on insulin sensitivity in nonobese, healthy older women., J Aging Phys Act, 13, 314, 10.1123/japa.13.3.314 · DOI
- Figueroa, 2003, Effects of exercise training and hormone replacement therapy on lean and fat mass in postmenopausal women., J Gerontol A Biol Sci Med Sci, 58, 266, 10.1093/gerona/58.3.M266 · DOI · Paper page
- Newman, 2006, Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort., J Gerontol A Biol Sci Med Sci, 61, 72, 10.1093/gerona/61.1.72 · DOI · Paper page
- Evidence Partners. DistillerSR: better, faster systematic reviews used systematic review software. https://www.evidencepartners.com/products/distillersr-systematic-review-software/. Published 2011. Accessed April 25, 2018.
Cited by
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
Roberts, M. D., McCarthy, J. J., Hornberger, T. A., Phillips, S. M., Mackey, A. L., Nader, G. A., Boppart, M. D., Kavazis, A. N., Reidy, P. T., Ogasawara, R., et al. (2023) · Physiological Reviews · doi:10.1152/physrev.00039.2022 · Cited by 214
Current and investigational medications for the treatment of sarcopenia
Rolland, Y., Dray, C., Vellas, B., & Barreto, P. D. S. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155597 · Cited by 195
Hamoda, H., Panay, N., Pedder, H., Arya, R., & Savvas, M. (2020) · Post Reproductive Health · doi:10.1177/2053369120957514 · Cited by 192
Hormone replacement therapy – Current recommendations
Vigneswaran, K., & Hamoda, H. (2022) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2021.12.001 · Cited by 151
The role of estrogen in female skeletal muscle aging: A systematic review
Critchlow, A. J., Hiam, D., Williams, R., Scott, D., & Lamon, S. (2023) · Maturitas · doi:10.1016/j.maturitas.2023.107844 · Cited by 80
dos Santos, E. E. P., de Araújo, R. C., Candow, D. G., Forbes, S. C., Guijo, J. A., de Almeida Santana, C. C., Prado, W. L. D., & Botero, J. P. (2021) · Nutrients · doi:10.3390/nu13113757 · Cited by 60
Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions
Wang, T., Zhou, D., & Hong, Z. (2025) · MedComm · doi:10.1002/mco2.70030 · Cited by 46
Protein Requirements for Master Athletes: Just Older Versions of Their Younger Selves
Moore, D. R. (2021) · Sports Medicine · doi:10.1007/s40279-021-01510-0 · Cited by 33
Metadata
- Authors
- Javed, A. A., Mayhew, A. J., Shea, A. K., & Raina, P.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2019-08-28
- Volume
- 2
- Issue
- 8
- Pages
- e1910154
- ISSN
- 2574-3805
- Cited by
- 105
- References
- 17
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.